Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × regorafenib × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

OTHER 127 INDUSTRY 50 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2 Sarcoma 2 Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

Fluorouracil 70 Leucovorin 45 Oxaliplatin 44 Capecitabine 39 Cisplatin 38 Gemcitabine 32 Radiotherapy 29 Irinotecan 27 Cetuximab 19 Paclitaxel 14 Bevacizumab 12 Docetaxel 9 dehydroftorafur 8 durvalumab 7 Taxes 7 Surgical Procedures, Operative 7 Mitomycin 7 Folfox protocol 7 Specimen Handling 6 S 1 (combination) 6 Panitumumab 6 Carboplatin 6 Watchful Waiting 5 Platinum 5 Imatinib Mesylate 5 Gene Expression Profiling 5 Epirubicin 5 Albumin-Bound Paclitaxel 5 130-nm albumin-bound paclitaxel 5 Trastuzumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02365441 2023-07-07

ALT GIST

Australasian Gastro-Intestinal Trials Group

Phase 2 Unknown

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡